A pilot study of perilymphatic leukocyte cytokine mixture (IRX-2) as neoadjuvant treatment for early stage cervical carcinoma: preliminary report-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A pilot study of perilymphatic leukocyte cytokine mixture (IRX-2) as neoadjuvant treatment for early stage cervical carcinoma: preliminary report

Published:2002-06 Issue:7 Volume:2 Page:1007-1016
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Dueñas-Gonzalez A,Verastegui E,Lopez-Graniel C,Gonzalez A,Mota A,Barrera-Franco J.L,Meneses A,Chanona J,de la Garza J,Chavez-Blanco A,Hadden J.W

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference38 articles.

1. Epidemiology of cervical cancer;Mohar;Cancer Invest.,2000

2. Is concurrent chemotherapy and radiotherapy the new standard of care for locally advanced cervical cancer?;Lehman;Int. J. Gynecol. Cancer,2001

3. Loss of MHC class I expression in cervical carcinomas;Connor;Int. J. Cancer,1990

4. Langerhans cells and epithelial cell modification in cervical intraepithelial neoplasia: correlation with human papillomavirus infection;Viac;Immunobiology,1990

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Immunotherapy for Cervical Cancer—A Systematic Review of Clinical Trials;Cancers;2022-01-17

2. IRX-2 natural cytokine biologic for immunotherapy in patients with head and neck cancers;OncoTargets and Therapy;2018-06

3. Immunostimulatory Activity of the Cytokine-Based Biologic, IRX-2, on Human Papillomavirus-Exposed Langerhans Cells;Journal of Interferon & Cytokine Research;2016-05

4. Non-steroidal anti-inflammatory drugs, tumour immunity and immunotherapy;Pharmacological Research;2012-07

5. IRX-2, a novel immunotherapeutic, protects human T cells from tumor-induced cell death;Cell Death & Differentiation;2009-01-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3